US 11479556
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted A61PA61P35/00A61P37/00
Quick answer
US patent 11479556 (Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway) held by NURIX THERAPEUTICS, INC. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NURIX THERAPEUTICS, INC.
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 106
- CPC classes
- A61P, A61P35/00, A61P37/00